Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic loudest to applaud CMS' (Centres for Medicare and Medicaid Services) new review of outpatient procedures

This article was originally published in Clinica

Executive Summary

The Centres for Medicare and Medicaid Services has agreed to alter Medicare's planned reimbursement for five device-related procedures performed in the outpatient setting after reviewing data supplied by manufacturers. The decision, announced October 31 in the agency's final rule for the outpatient prospective payment system for 2004, could be most helpful to Medtronic because it makes products affected by four of the five changes.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT065246

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel